Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Queensland Health
Johnson and Johnson
Chubb
US Department of Justice
UBS
Argus Health
AstraZeneca
Cipla

Generated: June 24, 2018

DrugPatentWatch Database Preview

Claims for Patent: 5,567,817

« Back to Dashboard

Summary for Patent: 5,567,817
Title: Triazole antifungal agents
Abstract:The invention provides antifungal compounds of the formula: ##STR1## and pharmaceutical salts thereof, wherein R is phenyl substituted by 1 to 3 substituents each independently selected from halo, --CF.sub.3 and --OCF.sub.3 ; R.sup.1 is C.sub.1 -C.sub.4 alkyl; R.sup.2 is H or C.sub.1 -C.sub.4 alkyl; X is CH or N; and Y is F or Cl.
Inventor(s): Ray; Stephen J. (Deal, GB2), Richardson; Kenneth (Birchington;, GB2)
Assignee: Pfizer Inc. (New York, NY)
Application Number:08/432,414
Patent Claims: 1. A compound of the formula ##STR52## or a pharmaceutically acceptable salt thereof, wherein R is 2,4-difluorophenyl, and R.sup.2 is hydrogen or methyl.

2. A compound of the formula ##STR53## or a pharmaceutically acceptable salt thereof, wherein R is 2,4-difluorophenyl, 2,4-dichlorophenyl, 2-chlorophenyl, 4-fluorophenyl, or 2-fluorophenyl.

3. 2-(2,4-difluo rophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, or a pharmaceutically acceptable salt thereof.

4. (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropy rimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, or a pharmaceutically acceptable salt thereof.

5. A pharmaceutical composition for treating a fungal infection in a mammal which comprise an effective amount of the compound of claim 1 and a pharmaceutically acceptable carrier.

6. A pharmaceutical composition for treating a fungal infection in a mammal which comprises an effective amount of the compound of claim and a pharmaceutically acceptable carrier.

7. A pharmaceutical composition for treating a fungal infection in a mammal which comprises an effective amount of the compound of claim 3 and a pharmaceutically acceptable carrier.

8. A pharmaceutical composition for treating a fungal infection in a mammal which comprises an effective amount of the compound of claim 4 and a pharmaceutically acceptable carrier.

9. A method of treating a fungal infection in a mammal which comprises administering to said mammal an effective amount of the compound of claim 1.

10. A method of treating a fungal infection in a mammal which comprises administering to said mammal an effective amount of the compound of claim 2.

11. A method of treating a fungal infection in a mammal which comprise administering to said mammal an effective amount of the compound of claim 3.

12. A method of treating a fungal infection in a mammal which comprised administering to said mammal an effective amount of the compound of claim 4.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Express Scripts
Teva
US Army
Deloitte
QuintilesIMS
US Department of Justice
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.